SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tktrimbath who wrote (382)5/24/2003 10:15:23 AM
From: Mike McFarlandRead Replies (3) of 557
 
Stock still moving up--only burned 375k this in
the quarter ended March 31st.

Doing well recently compared to other gene
therapy stocks perhaps, although now that
I think about it, cege has moved away from
GT and is focused on cancer.

finance.yahoo.com

Just don't click on the two and five year charts,
heheh, only outperforming in the short term.

................................................
fun with lists

A list of GT companies.
ispex.ca

www1.frost.com
The following is a list of key industry participants: Advanced Therapies, Inc.; ALZA Corp.; Apoptogen, Inc.; Aradigm Corp.; ARIAD Pharmaceuticals, Inc.; Athersys, Inc.; Aventis Gencell; Avigen, Inc.; BD Biosciences Clontech; BioDelivery Sciences International, Inc.; Bio-Rad Laboratories, Inc.; BioStratum, Inc.; Biovector Therapeutics, S.A.; Canji, Inc.; Cell Gensys, Inc.; Chromos Molecular Systems, Inc.; Collateral Therapeutics, Inc.; Copernicus Therapeutics, Inc.; Dendritech, Inc.; Endocyte, Inc.; Endovasc, Ltd., Inc.; Enzo Biochem, Inc.; F.H. Faulding & Co., Ltd.; Genelabs Technologies, Inc.; Genetic Therapy, Inc.; Genetix Pharmaceuticals, Inc.; Genetronics Biomedical, Ltd.; GenStar Therapeutics Corp.; GenVec, Inc.; Genzyme Corp.; Glygen Corp.; Immune Response Corp.; Inex Pharmaceuticals, Inc.; Intronn, LLC; InvivoGen; Lexicon Genetics, Inc.; Nature Technology Corp.; Onyx Pharmaceuticals, Inc.; Polygenetics, Inc.; REPLICor, Inc.; RHeoGene, LLC; Ribozyme Pharmaceutical, Inc.; Selective Genetics, Inc.; StemCells, Inc.; StressGen Biotechnologies Corp.; Targeted Genetics Corp.; Theratechnologies, Inc.; Therion Biologics Corp.; Titan Pharmaceuticals, Inc.; Tosk, Inc.; Transkaryotic Therapies, Inc.; Valentis, Inc.; ValiGen, Inc.; and Vical, Inc.

A large PDF that might be worth a look--gene therapy
in Europe, a couple years old
sussex.ac.uk

A comprehensive list of biopharm companies
researchandmarkets.com

Why pointing to long lists today? I'm almost completely
out of the stock market now. I wont use any of my dry
powder again til something walks up and bites me on the
nose.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext